Depressive Disorder, Major Clinical Trials in New York, New York

3 studies are recruiting for depressive disorder, major in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

    The purpose of this study is to know how well seltorexant works, and also to evaluate safety and maintenance effect of seltorexant compared with placebo as an adjunctive therapy to an antidepressant in improving depressive symptoms in participants with major depressive disorder with insomnia sympto…

    Stage
    Phase 3
    Ages
    18 to 74
    Site
    Fieve Clinical Research Inc, New York, New York
    Locations
    205 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT06559306 on ClinicalTrials.gov

  2. A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

    The main purpose of this study is to assess how well the study drug (JNJ-42847922) works (efficacy) compared with placebo in improving depressive symptoms in participants with major depressive disorder ([MDD], a common mood disorder that causes a lasting feeling of sadness and a loss of interest in…

    Stage
    Phase 3
    Ages
    18 to 74
    Site
    Fieve Clinical Research Inc, New York, New York
    Locations
    39 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07573176 on ClinicalTrials.gov

  3. A Study of Brenipatide in Adult Participants With Major Depressive Disorder

    This study evaluates the safety and efficacy of brenipatide when administered with standard of care (SoC) compared to placebo plus SoC in delaying the return of major depressive symptoms. The trial is divided into three periods as follows: a screening period that will last approximately 1 month, a …

    Stage
    Phase 3
    Ages
    18 to 75
    Site
    Adams Clinical Harlem, New York, New York
    Locations
    179 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07412756 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.